A prospective randomized cotrolled study comparing EUS sonopsy CY and 22G EUS-FNAB needles for EUS-guided fine-needle aspiration of solid pancreatic mass lesions and swelling lymph node

A prospective randomized cotrolled study comparing EUS sonopsy CY and 22G EUS-FNAB needles for EUS-guided fine-needle aspiration of solid pancreatic mass lesions and swelling lymph node - A prospective randomized cotrolled study comparing EUS sonopsy CY and 22G EUS-FNAB needles for EUS-guided fine-needle aspiration of solid pancreatic mass lesions and swelling lymph node

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021779

Enrollment

100

Registered

2016-04-05

Start date

2015-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid pancreatic mass lesions and swelling lymph nodes

Interventions

In EUS-FNA, 1st and 3rd puncture using EUS sonopsy CY, 2nd and 4th puncture using 22GEUSFNAB needle(EchoTip Procore). In EUS-FNA, 1st and 3rd puncture using 22GEUSFNAB needle(EchoTip Procore), 2nd and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pancreatic mass or swelling lymph node who are refered to EUS-FNA

Exclusion criteria

Exclusion criteria: 1.Performance Status (PS)4. 2.The patient who has serious disease. 3.The pacient with anticoagulant therapy. 4.The woman becomes pregnant or might be pregnant. 5.Insertion of the endoscope is impossible. 6.The patient was judged the physician to be inappropriate.

Design outcomes

Primary

Measure	Time frame
The tissue collection rate and accuracy rate in each group.	—

Countries

Japan

Contacts

Public ContactRyo IGARASHI

Fukushima Medical University Aizu Medical Center gastroenterology

ryo-i@fmu.ac.jp(0242)75-2100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026